Trader consensus on an 82.5% chance of no new COVID variant of concern before 2027 stems primarily from the absence of any SARS-CoV-2 strain meeting WHO or CDC criteria for that designation since JN.1 in late 2023. Highly mutated lineages such as BA.3.2, now circulating in multiple countries and U.S. states with dozens of spike-protein changes, remain classified only as variants under monitoring because they have not produced clear increases in transmissibility, severity, or immune escape beyond current levels. Ongoing genomic surveillance and wastewater data show steady circulation without case surges, supported by population-level immunity from prior infections and the 2025–26 vaccines. This pattern of contained evolution under endemic conditions keeps the bar for a new variant of concern high through the end of 2026.